Amyloid-β oligomers in cellular models of Alzheimer's disease

Area of Science:

• Neuroscience
• Biochemistry
• Pathology

Background:

• Amyloid-beta (Aβ) dysmetabolism is a key factor in Alzheimer's disease (AD) pathogenesis.
• Aβ aggregates into fibrils forming plaques and soluble oligomers (AβOs), which are implicated in neurotoxicity.

Purpose of the Study:

• To review the physicochemical properties of AβOs.
• To examine the impact of AβOs on various brain cell types in AD.
• To summarize evidence on cell-specific toxicity mechanisms of AβOs.

Main Methods:

• Review of three decades of scientific literature on AβOs.
• Analysis of physicochemical properties and cellular effects of AβOs.
• Discussion of findings from cellular models of AD.

Main Results:

• Soluble AβOs exhibit significant synaptotoxic and neurotoxic effects.
• Evidence highlights cell-specific mechanisms through which AβOs exert toxicity.
• Cellular models provide valuable insights into AβO detrimental effects.

Conclusions:

• Understanding AβO properties and cell-specific toxicity is crucial for AD research.
• Cellular models are instrumental in elucidating AβO-induced damage.
• This knowledge may pave the way for developing novel therapeutic strategies for AD.